New Zealand - engelsk - Medsafe (Medicines Safety Authority)

pacific pharmaceuticals limited (part of mylan) - fluphenazine decanoate 25 mg/ml;   - solution for injection - 25 mg/ml - active: fluphenazine decanoate 25 mg/ml  

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - fluphenazine decanoate 100 mg/ml;   - injection (depot) - 50 mg/0.5ml - active: fluphenazine decanoate 100 mg/ml   excipient: sesame oil

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

hospira nz ltd - fluphenazine decanoate 100 mg/ml;   - injection (depot) - 100 mg/ml - active: fluphenazine decanoate 100 mg/ml   excipient: benzyl alcohol sesame oil

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

hospira nz ltd - fluphenazine decanoate 25 mg/ml;   - injection (depot) - 25 mg/ml - active: fluphenazine decanoate 25 mg/ml   excipient: benzyl alcohol sesame oil

Armenien - engelsk - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

krka d.d. - fluphenazine (fluphenazine decanoate) - solution for i/m injection - 25mg/ml

Armenien - engelsk - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

krka d.d. - fluphenazine (fluphenazine decanoate) - solution for i/m injection - 25mg/ml

Irland - engelsk - HPRA (Health Products Regulatory Authority)

bristol-myers squibb pharmaceuticals uc - fluphenazine decanoate - solution for injection - 100 mg/ml - fluphenazine

Bangladesh - engelsk - DGDA (Directorate General of Drug Administration)

gonoshasthaya pharmaceuticals ltd. - fluphenazine decanoate - injection - 25 mg/ml

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

bristol-myers squibb (nz) limited - fluphenazine decanoate 25 mg/ml (26.88mg added to provide 25mg/ml plus a 7.5% excess.) - injection (depot) - 25 mg/ml - active: fluphenazine decanoate 25 mg/ml (26.88mg added to provide 25mg/ml plus a 7.5% excess.) excipient: benzyl alcohol nitrogen sesame oil - fluphenazine decanoate is indicated in the long-term management of psychotic disorders including schizophrenia, mania and organic brain syndrome. it is of particular value in the treatment of chronic schizophrenia and for patients who are unreliable at taking oral medication. the drug often alleviates such target symptoms as hallucinations, delusions, confusion and withdrawal. it is not only useful in the hospital milieu but is unparalleled, because of its long duration of action in the long-term maintenance therapy of chronically psychotic patients who are amenable to out-patient therapy. fluphenazine decanoate has not been shown to be effective in the management of behavioural complications in patients with mental retardation.

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

bristol-myers squibb (nz) limited - fluphenazine decanoate 100 mg/ml - injection (depot) - 100 mg/ml - active: fluphenazine decanoate 100 mg/ml excipient: benzyl alcohol sesame oil - fluphenazine decanoate is indicated in the long-term management of psychotic disorders including schizophrenia, mania and organic brain syndrome. it is of particular value in the treatment of chronic schizophrenia and for patients who are unreliable at taking oral medication. the drug often alleviates such target symptoms as hallucinations, delusions, confusion and withdrawal. it is not only useful in the hospital milieu but is unparalleled, because of its long duration of action in the long-term maintenance therapy of chronically psychotic patients who are amenable to out-patient therapy. fluphenazine decanoate has not been shown to be effective in the management of behavioural complications in patients with mental retardation.